Highlights

  • Climb increased second-quarter gross billings 17% to USD 587.3 million, outpacing the growth in net sales.
  • Higher selling, general and administrative expenses offset gross profit growth and left adjusted EBITDA broadly unchanged.
  • The Distribution segment increased gross billings 18%, while the smaller Solutions business recorded a more modest expansion.
  • Climb ended June without debt and left its revolving credit facility undrawn as cash increased during the half-year.

More business passed through Climb Global Solutions (NASDAQ:CLMB) in the second quarter, yet earnings slipped as operating expenses absorbed the increase in gross profit. The technology distributor reported stronger billings and sales for the period ended 30 June 2026. Its debt-free balance sheet contrasted with a weaker effective margin, making cost conversion the main tension in the results.

Billings Outrun Recognised Sales

Results released on 29 July showed gross billings of USD 587.3 million, up 17% year on year. Net sales increased 9% to USD 174.2 million, while gross profit rose 15% to USD 30.2 million.

The separate measures describe different aspects of activity. Gross billings capture the volume flowing through the distribution business, while net sales reflect revenue recognition. Billings expansion consequently exceeded the increase in recognised sales, creating two different measures of growth.

Distribution accounted for most activity, with gross billings of USD 562.9 million, up 18%. The Solutions segment generated USD 24.4 million, an increase of 4%. The two segments consequently contributed very different rates of expansion.

Expenses Absorb Gross Profit Gains

Selling, general and administrative expenses increased to USD 20.7 million from USD 16.4 million. Against that higher cost base, adjusted EBITDA was USD 11.3 million, compared with USD 11.4 million a year earlier.

Net income declined to USD 5.5 million from USD 6.0 million. Diluted earnings per share fell to USD 0.30 from USD 0.33, despite the increases in net sales, billings and gross profit.

The company-defined effective margin, calculated as adjusted EBITDA relative to gross profit, narrowed to 37.5% from 43.3%. That measure shows the reduced conversion of gross profit into adjusted EBITDA. It supplements the reported earnings figures rather than replacing them.

SG&A represented 3.5% of gross billings, compared with 3.3% a year earlier. The expense increase consequently affected both absolute earnings and the relationship between costs and business volume.

Cash Rises Without Borrowing

Cash reached USD 56.6 million at 30 June, compared with USD 36.6 million at 31 December 2025. Climb reported no debt and had made no drawings on its USD 50 million revolving credit facility.

The release did not announce a dividend or provide quarterly or annual revenue and earnings guidance. Those omissions limit the available near-term financial targets; the balance sheet does not establish that management has committed the cash to any particular transaction.

Long-Term Ambition Depends on Execution

Climb reiterated its objective of more than doubling fiscal 2025 adjusted EBITDA by 2030. It identified organic growth, selective expansion of vendor line cards and Europe as elements of that ambition.

The objective remains a long-term goal rather than a year-by-year earnings forecast. The latest quarter illustrates the distinction: activity expanded, but adjusted EBITDA remained broadly flat because the increase in expenses absorbed additional gross profit.

Future reporting will show whether those costs begin to support stronger earnings conversion. Gross profit, SG&A and effective margin provide linked measures of that progress. Developments in vendor relationships and European expansion will add operational context, although no date for the next quarterly report was confirmed.